Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO-Immuno-Oncology-2024-1000x250

Coming Soon

11/12/2024

Regeneron
Breaking the barriers in advanced non-melanoma skin cancer: How can we optimise immunotherapy to elevate response and combat resistance?
  • Welcome and introductions
    Olivier A. Michielin
  • Redefining strategies in advanced cutaneous squamous cell carcinoma to circumvent resistance in non-responders and progressors
    Christoffer Gebhardt
  • Leveraging cancer-immune Interactions to enhance therapeutic approaches in advanced basal cell carcinoma
    Egle Ramelyte
  • The Future of immunotherapy and molecularly driven therapeutics in advanced non-melanoma skin cancer
    Olivier A. Michielin
  • Panel discussion
    Egle Ramelyte

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.